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Abstract
The objective of this project is to demonstrate new enabling technology for 
multiplex biodetection systems that are flexible, miniaturizable, highly automated, low 
cost, and high performance.  It builds on prior successes at LLNL with particle-based 
solution arrays, such as those used in the Autonomous Pathogen Detection System 
(APDS) successfully field deployed to multiple locations nationwide.  We report the 
development of a multiplex solution array immunoassay based upon engineered metallic 
nanorod particles.  Nanobarcodes® particles are fabricated by sequential electro-
deposition of dissimilar metals within porous alumina templates, yielding optically 
encoded striping patterns that can be read using standard laboratory microscope optics 
and PC-based image processing software.  The addition of self-assembled monolayer 
(SAM) coatings and target-specific antibodies allows each encoded class of nanorod 
particles to be directed against a different antigen target.  A prototype assay panel 
directed against bacterial, viral, and soluble protein targets demonstrates simultaneous 
detection at sensitivities comparable to state of the art immunoassays, with minimal 
cross-reactivity.  Studies have been performed to characterize the colloidal properties 
(zeta potential) of the suspended nanorod particles as a function of pH, the ionic strength 
of the suspending solution, and surface functionalization state.  Additional studies have 
produced means for the non-contact manipulation of the particles, including the insertion 
of magnetic nickel stripes within the encoding pattern, and control via externally applied 
electromagnetic fields.  Using the results of these studies, the novel Nanobarcodes®
based assay was implemented in a prototype automated system with the sample 
processing functions and optical readout performed on a microfluidic card.  The unique 
physical properties of the nanorod particles enable the development of integrated 
microfluidic systems for biodefense, protein expression studies, and other applications.  
Introduction/Background
Multiplex bioassays are critical for biodefense and medical diagnostic 
applications. In many cases, multiple threat agents must be screened simultaneously, or 
multiple samples must be rapidly tested [1]. Host-response assays require detection and 
monitoring of combinations of biomarkers, including DNA, RNA, proteins, and small 
molecules. While tremendous advances in multiplexed biomarker analysis have come 
about with the advent of DNA and protein chips, this technology is limited in several 
important ways (see Table I for a comparison between solution arrays and chip 
technology): (1) microarrays are 2-dimensional, limiting interaction with target 
molecules; (2) gene and protein chips are aimed at only one type of marker (DNA, RNA, 
or protein);  (3) DNA and protein chips are not reconfigurable; and (4) microarray 
technologies require the manufacture of specific chips, an approach that is expensive and 
time consuming. Solution arrays address all of these shortcomings.
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Table I.  Comparison of solution arrays and 2-D microarrays.
Solution arrays are similar in purpose to gene and protein array chips, but use 
surface functionalized particles in solution, rather than a 2-D chip that binds the 
biomolecules to locations on a fixed surface. A fluorescent signal is typically used to 
report a binding event; instead of correlating fluorescence with location, as in a chip 
format, the particles are encoded for identification, so that fluorescence is correlated with 
particle type. The solution array concept is illustrated in Figure 1.  The different particles 
are mixed with the sample, and any target molecules in the sample are captured by the 
particles that are specifically functionalized for them.  After the excess sample is washed 
away, reporter molecules (identical to those on the particles) tagged with fluorophore are 
introduced, and these bind to any target molecules that were captured on the surfaces of 
the particles.  Then the excess reporter is washed away and the particles are examined; 
any that are fluorescent are known to have found their target molecules in the sample, and 
by determining the “flavors” of the fluorescent particles, it can be determined which 
targets have been found.  
 
Potential particles must have two properties: they must be capable of being 
functionalized to exhibit specific reactivity with selected biochemical targets, and each 
class or “flavor” of particle specific to a particular target must be readily distinguishable 
by the detection system.  The general advantages of a solution array approach over the 
chip-based approach include faster reaction kinetics, the ability to perform immunoassays 
and nucleic acid hybridization assays simultaneously on the same sample, the flexibility 
to assemble a custom assay panel at the point of use by mixing and matching the particle 
“flavors” of most interest, and avoidance of the cost and delay involved in producing a 
unique chip design.
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Figure 1.  Illustration of the solution array concept.
Past work at LLNL has focused on Luminex fluorescent beads. This has enabled
very successful large-scale automated multiplex biodetection systems such as the 
Autonomous Pathogen Detection System (APDS) [2]. These polymer beads are encoded 
spectroscopically, and as a result require the use of fairly sophisticated and expensive 
flow cytometers or similar optical systems for readout. Requirements are motivating 
research into miniaturized biodetection systems that integrate multiple functions within a 
compact unit [3-6]. Preliminary work in implementing fluorescent bead based solution 
array assays in a microfluidic format revealed difficulties in handling and processing 
beads because it proved difficult to retain the beads in place during incubation and 
washing steps, and the beads tended to adhere to the inner surfaces of the microfluidic 
channels and wells [7].  
We have chosen to demonstrate a novel solution array bioassay system using 
Nanobarcodes® particles as the solution array elements.  Nanobarcodes® (Figure 2) are 
metallic nanorod particles, approximately 250 nm in diameter and 6 microns long, 
developed by Nanoplex Technologies, Inc.  They are fabricated by sequential 
electrodeposition of silver, gold, or other metals within porous anodic alumina templates.  
The alternating segments of silver and gold have different reflectivities when viewed in 
blue light, so when the finished particles are present in solution they can be readily 
identified visually, using a standard optical microscope.  The striping patterns are 
conceptually the same as the barcode patterns used to identify items in a supermarket.  
The soft metals used mean that well-understood alkanethiol chemistry can be used to 
functionalize the particle surfaces, and they can be made with magnetic materials, 
opening up new possibilities for manipulating, trapping, and reading the particles. 
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Figure 2.  Nanobarcodes®™ particles contain a striping pattern, visible in blue light, that allows them to be 
readily identified in the same way as supermarket barcodes.
In the solution array assay implementation, the assay results are determined by 
obtaining a matched pair of images of the particles in blue reflected light (darkfield), and 
in fluorescence.  The reflectance image provides the identity of each of the visible 
particles, and the fluorescence image indicates the degree of antigen binding.  Figure 3
shows such a pair of images.  The images can be obtained using standard microscope 
hardware, and the images can be processed using a PC to collect the results for a 
multiplex assay involving many simultaneous particle types / antigen targets.
 
Figure 3.  A reflectance / fluorescence image pair, used to read the results of a Nanobarcode based solution 
array assay.  The absence of fluorescence from several of the particles (indicated at right) shows that the 
target for those particles was absent from the sample.
The objective of this project is to demonstrate microfluidic system technologies for 
performing automated solution array assays based on Nanobarcodes® particles. The 
techniques we demonstrate can be applied to the detection and identification of 
biowarfare (BW) agents, and presymptomatic exposure to BW agents and infectious 
diseases.  Specific technical objectives fell into 4 areas: 1. assay development, 2. particle 
manipulation and control, 3. optical readout, and 4. microfluidic device integration. 
Research Activities
At project initiation, it was decided to focus work on the scientifically critical 
questions limiting the deployment of fieldable solution array bioassays, and not on 
engineering component development.  Hence, there was no effort to develop unique 
miniaturized optical imaging equipment, miniature fluid pumps, compact power sources 
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and so on.  Development of components is expensive and is being addressed by other 
projects both at LLNL and in the larger research community.
The structure of the project focused early phases of the work on the enabling 
technologies of assay development, particle manipulation and control, and optical 
readout.  Once sufficient progress had been achieved in these enabling technologies, they 
were brought together to address the objective of microfluidic device integration.
1. Assay Development
The first critical objective was the demonstration of a multiplex biodetection 
assay based on Nanobarcodes® particles that shows good performance on the benchtop.  
Only after the basic assay is successfully demonstrated with manual benchtop techniques
can it be confidently transitioned to an automated, microfluidic format.  Nanoplex 
Technologies, Inc. had made some initial studies of Nanobarcodes® based multiplex 
immunoassays directed against purified cytokines, using highly optimized commercial 
medical antibodies.  Our aim was to extend this work to biodetection assays using 
currently available bioagent simulant antigen–antibody systems and realistic antigen 
samples.
Assay performance is based on optimized functionalization of the particles.  The 
first step in the functionalization is the addition of a thiol-linked self-assembled 
monolayer (SAM) coating.  As described in the following section, several alternative 
SAM coatings were evaluated for their ability to provide zeta potential enhancement and 
inhibit particle aggregation and adhesion.  In all cases, the basic structure of the SAM 
coating and protein functionalization resembles that shown in Fig. 4.  Each SAM 
molecule spontaneously bonds to the metal surface via a sulfur thiol linkage, and presents 
a carboxyl residue at its free end.  This carboxyl terminus allows for the easy conjugation 
of proteins (e.g. antibodies) to the coated particles by means of Sulfo-NHS chemistry.  
Figure 4.  Structure of the self-assembled monolayer (SAM) and protein coating for the particles.  
Carboxyl-terminated SAM molecules bind to the metal surface via sulfur thiol bonds (a), and proteins such 
as antibodies are covalently attached in order to provide the specific biochemical affinity (b).
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The chosen SAM coating was 11-mercaptoundecanoic acid (MUA).  A 5-plex 
biodetection assay panel was designed, consisting of 5 unique striping patterns or 
“flavors” of particles, with particles of different patterns functionalized with antibodies 
against Bacillus globigii (Bg) bacterial spores, MS2 bacteriophage virus, and ovalbumin 
protein, plus two controls.  These three target antigens were chosen as surrogates for 
bacterial, viral, and protein (biotoxin) threats.  The positive control particles were made 
by conjugating fluorescently labeled antibody directly to the particles, and the negative 
controls were made by conjugating nonfluorescent bovine serum albumin (BSA) protein 
to the particles.  Once early results showed that the conjugation method was reliable, the 
positive control was generally omitted, as the bright glow from the positive control 
particles tended to complicate the readout for the other flavors.
The resulting 4-plex assay panel (shown in Table 2) was used to test the assay 
performance, and to evaluate several alternative sulfo-NHS based protocols, as well as 
several post-conjugation blocking treatments used to limit nonspecific binding reactions 
and thereby boost the assay’s signal-to-noise ratio. The assay steps were carried out 
within 1.5 ml Eppendorf-type centrifuge tubes, with benchtop agitators, centrifuges, and 
pipettors used to manually carry out the steps of the procedure.  The results of the 
completed assays were read by imaging the particles and performing image analysis as 
described in Section 3 below.
Table 2.  Particle “flavors” and functionalizations for the 4-plex biodetection assay.
As a result of this work, a 4-plex Nanobarcodes® based assay panel was shown to 
have high performance.  The previous cytokine work had shown that the sensitivity of the 
Nanobarcodes® assay (the limit of detection) is similar to that for state of the art 
immunoassays, with low nanomolar or even picomolar sensitivity when optimized 
antibodies are used.  Biodetection immunoassays are more often limited by the binding 
constants of the less perfect antibodies and the nonideal (i.e. particulate and 
inhomogenous) state of the antigen target, nonetheless the performance of the assay was 
quite high.  Example results for one test series are given in Fig. 5, showing the 
fluorescent intensities of each flavor particle as a function of the concentration of samples 
containing Bg spores.  There is minimal cross-talk between particle flavors, indicating 
little nonspecific binding.  The signal-to-noise ratio is approximately 10.
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Figure 5.  Sample results from a series of 4-plex Nanobarcodes®-based assays showing highly specific and 
sensitive detection of Bg spores.
Once magnetic Nanobarcodes® particles became available (as described in 
section 2 below), the assay panel was re-implemented using the magnetic particles, with 
no change in performance.
2. Particle Manipulation and Control
One of the main motivations for the Nanobarcodes® format is the advantage it 
promises for particle manipulation and control.  The functionalization of the metal 
surfaces permits good control over the surface properties, and the physical properties of 
the particles allow for easy separation and manipulation, particularly using electrical and 
magnetic fields.  These issues are critical for implementing the assay in a high surface 
area microfluidic environment.
Initial studies were performed in order to predict the behavior of metallic nanorod 
particles under the influence of Brownian motion, and external electric fields.  The output 
of a numerical model of the induced field around such a particle in an electric field is 
shown in Figure 6.  Such induced fields lead to particle rotation and alignment with the 
external field lines.  Experimental studies were also performed.  The imposition of a DC 
electric field across a suspension of Nanobarcodes® particles causes some alignment of 
the particles, but the bulk electrophoretic migration of the particles is much more 
significant.  If however an AC field is applied, with a frequency over approximately 100 
Hz, there is no net movement of the particles and they align strongly along the field lines.  
Brownian motion, the random translational and rotational movement of very small 
particles, is seen to be an important contributor to Nanobarcode behavior, and is a 
limiting factor in the degree of uniformity that can be attained using different means of 
manipulation.  Figure 7 shows the results of analytical prediction and experimental work 
showing the degree of particle alignment achieved using AC fields of different 
intensities.
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Figure 6.  Model results showing the induced field around a metallic Nanobarcode particle in an external 
electric field.
Figure 7.  Theoretical and experimentally observed angular alignment of pure silver and half silver/half 
gold particles in AC fields of different magnitudes.  The sharpness of the distribution indicates the degree 
of alignment with the electric field direction.  Models were developed for particles in both high and low 
conductivity solutions (lD >> radius and lD << radius).  Alignment is limited by the Brownian motion of 
the particles (all data taken at room temperature).
A major experimental undertaking was the measurement of the electrokinetic 
properties of surface-functionalized metallic nanorod particles within aqueous 
suspension.  Despite its relevance to nanoparticle science of many types, very little 
published data on this subject exists in the literature.  The main property of concern is the 
zeta potential, or net charge on the surface of a particle immersed in liquid.  This net 
charge not only determines the electrophoretic mobility of the particle within an external 
electric field, but is also a main determinant of particle aggregation and sticking to 
surfaces.  Higher zeta potentials allow more effective manipulation with electric fields, 
and high zeta potentials of like sign serve to mutually repel particles and surfaces, 
preventing sedimentation and adhesion.  Our results revealed the zeta potential behavior 
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of particles of gold, silver, and palladium, both uncoated and SAM coated, for solutions 
of different saline concentrations and pH values.  We also compared the zeta potential 
effects of a number of different SAM coatings, data which led to the selection of MUA as 
the optimal choice.  The experiments also included the effect of protein conjugation.  As 
examples of the information gained from these experiments, Figure 8 shows the relative 
zeta potential effects of a number of alternative SAM coatings on pure gold particles 
within 10 mM NaCl solutions, and Figure 9 shows the zeta potential behavior of particles 
functionalized with ovalbumin protein or anti-ovalbumin antibodies.  Among the findings 
was that the pH of the solution has a very significant effect on the zeta potential; very 
acidic solutions are to be avoided.
Figure 8.  Results of zeta potential tests showing the effect of several alternative SAM coatings applied to 
unstriped gold particles, in 10 mM NaCl solution. The MUA coating provides the greatest zeta potential 
enhancement.  
Figure 9.  Results of zeta potential tests showing the effect of protein conjugation on unstriped gold 
particles in 10 mM NaCl.  Sample proteins included ovalbumin and anti-ovalbumin antibody. Absolute 
values over 30 mV are sufficient to minimize aggregation.
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Flow tests were performed in order to confirm that the functionalized 
Nanobarcodes® particles would flow through microchannels of the intended materials 
without aggregation or sticking.  Figure 10 is a captured image from a video of MUA-
coated particles flowing in dispersed suspension through a PDMS silicone-on-glass 
microchannel.  These tests raised confidence that properly coated particles would move 
without difficulty through the planned microfluidic system.
Figure 10.  A video frame from tests of particle flow in microfluidic channels showing MUA-coated 
Nanobarcode particles flowing without aggregation through a PDMS-on-glass microchannel under pressure 
driven flow.
In addition to the alignment within electric fields made possible by the zeta 
potential of conductive nanorod particles, the integration of magnetic material within the 
particles allows for manipulation within magnetic fields.  In the case of Nanobarcodes®
this is accomplished by inserting ferromagnetic nickel segments into the striping pattern.  
Nickel stripes were initially located at the center of the particles, and while this allowed 
for manipulation it also caused some particles to break in half.  Later particles included 
nickel stripes at the particle ends.  Subsequent work determined the magnetophoretic 
velocity of particles containing magnetic stripes of different length, as shown in Figure 
11.
Figure 11.  Magnetophoresis results showing the mobility of particles containing ferromagnetic nickel 
segments of different lengths.  Practical segment length was limited by aggregation of the magnetic 
particles containing nickel stripes over about 50 nm.  
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The results of the experiments summarized in this section revealed powerful ways 
of controlling the particles within automated assay devices.  In each case they also 
revealed practical limitations to these mechanisms.  In the case of electrical field 
alignment, strong AC fields led to strong particle alignment but eventually to particle 
aggregation, as the induced fields caused adjacent particles to gradually form “rafts” of 
particles aligned with the electric field.  Similarly, if too much nickel was integrated into 
the particles, the magnetic dipoles would induce north-south alignment of adjacent 
particles, causing them to collect in pairs or groups.  In the latter case it was determined 
that 50 nm was an optimal length for the Ni stripes.      
3. Optical Readout
The optical readout method avoids the use of flow cytometers and other expensive 
components by using image processing of the images collected from a standard 
epifluorescent microscope, of the type found in many microbiology laboratories.  Some 
additions, such as an autofocus stage and computer software control, were made in order 
to automate the image collection.  A pair of images, such as shown in Figure 3 above, is 
taken of the same field of particles that have completed the assay process, one image in 
reflected blue light, and the other in fluorescence (in a wavelength corresponding to the 
emission of the reporter molecule).  The reflectance image is analyzed to determine the 
“flavor” of each particle in the field of view, and the corresponding fluorescence image 
reveals how much antigen target is bound to each particle.  By correlating the images, a 
data file is constructed showing the average relative intensity of each particle flavor.
The image capture was done using a Zeiss Axiovert S100 inverted epifluorescent 
microscope with some added components as mentioned.  Best results were obtained using 
a 63x oil immersion objective lens.  The automated processing of the acquired images 
was performed by the custom image processing software package NBSee™ developed by 
Nanoplex Technologies, Inc.
As a result of the early experiments in the optical readout of Nanobarcode 
particles, it became clear that a major limitation on the readout efficiency was the number 
of particles that touched or overlapped other particles upon random sedimentation into 
the viewing plane.  The image processing system was usually unable to read such 
particles, and they were discarded from the data set.  Based upon the knowledge gained 
in the particle manipulation investigations, it was possible to devise a simple 
enhancement to increase the readout effectiveness by aligning most of the particles in a 
single direction, reducing touches and overlaps.  While this could be accomplished using 
AC electric field alignment, it was also possible to do this passively by relying upon the
large negative zeta potential of the particles and the similar large negative zeta potential 
of glass.  Patterns of parallel grooves were lithographically etched into the surface of the 
glass substrate; when particles sediment onto the grooved surface they move randomly 
due to Brownian motion, and if they remain unadhered due to mutual double layer
repulsion, eventually settle into the defined grooves.  A number of groove patterns were 
tested and the optimal results were obtained with narrow grooves 500 nm across, with a 
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depth of 500 nm and 6 micron spacing.  Figure 12 shows the effect of such a grooved 
substrate on the alignment of particles.  
Figure 12.  Photo and angular orientation histogram of Nanobarcodes® particles passively aligned on a 
lithographically grooved substrate for improved imaging.
4. Microfluidic Integration
The final phase of the project involved the integration of the techniques and 
knowledge gained during earlier phases into a demonstration of a prototype 
Nanobarcodes® particles-based automated microfluidic assay system.  The experimental 
setup included the inverted microscope and computer used in prior investigations, along 
with several items of additional equipment.  
The key steps of the process were carried out in a polymer/glass microfluidic 
card, shown schematically in Figure 13.  The structure was fabricated by casting a layer 
of polydimethylsiloxane (PDMS) on a gold-coated mold composed of patterned SU-8 
epoxy features on a silicon wafer.  After curing, the cast PDMS was removed from the 
mold and bonded to a glass substrate via a standard oxygen plasma activated contact 
bonding process.  For particle alignment, the portion of the glass substrate located at the 
imaging well was patterned with lithographically defined grooves.  Fluid access vias 
were formed by precision-punching holes through the PDMS into the inlet and outlet 
reservoirs and inserting metal connecting pins that were then connected to 1/16” tygon 
tubing.
Figure 13.  Schematic layout of the microfluidic card.
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A custom microscope stage was constructed to hold the microfluidic card.  In 
addition, the stage included brackets to hold an electromagnet, interfacing with the assay 
(capture) well from beneath, and a miniature 40 kHz ultrasonicator converter-horn 
assembly, contacting the assay well from above.  In order to better enhance and focus the 
magnetic field of the electromagnet within the small assay well, a custom-machined 
metallic focusing cone was bonded to the core of the electromagnet.  The stage was 
designed so that the microscope objective could view the detection well while the other 
hardware interfaced with the assay well.  An image of a microfluidic card in operating 
position is shown in Figure 14.
Figure 14.  A completed microfluidic card in position within the custom microscope stage.  The microscope 
objective is located beneath the detection well at left, while the ultrasonic horn (and electromagnet, 
underneath) interface with the assay well.
The microfluidic card is connected to an external fluidic control system (FlowPro, 
Global FIA).  All the components were centrally controlled using scripts implemented 
using custom LabView-based instrument control software originally developed for the 
control of autonomous pathogen detection systems.  During operation, the sample 
(including magnetic Nanobarcodes® particles) is introduced and flows through the assay
well, where the energized electromagnet captures the magnetic particles and retains them 
while the remainder of the sample is flushed from the well. Tests showed the capture 
electromagnet to be effective (Figure 15).  Washes are accomplished by passing clean 
rinse buffer over the captured Nanobarcodes® particles, which are subsequently 
resuspended by a short (approximately 100 ms) burst of cavitating ultrasound from the 
ultrasonicator horn.  After introduction of the reporter antibody, the particles are 
resuspended for a final time and transported to the imaging well for readout.
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Figure 15.  Results of optical measurements of particle capture near the magnet during flow through a 
PDMS-on-glass microchannel.  The data in blue correspond to a magnet with integrated focusing cone, as 
used in the final system.  The results show very dense and localized capture at the cone tip.
The microfluidic system described functioned well, and work was partially 
complete to transition the full multiplex assay protocol to the card format when the 
project funding was concluded.  A computer-controlled protocol was written and tested 
for the magnetic extraction and readout of Nanobarcodes® particles embedded in 
explosives as a means of tagging the material for forensic attribution.  In this application, 
a sample of explosive residue (Comp B, consisting of 63% RDX, 36% TNT, and 1% 
wax) with included Nanobarcodes® was withdrawn from an eppendorf tube and 
transferred into the capture well of the microfluidic card under the control of the 
automated fluidic system.  The electromagnet extracted the particles and the capture well 
was rinsed with buffer.  The ultrasonicator resuspended the captured particles, and they 
were automatically transferred to the imaging well.  The Nanobarcode tag particles were 
imaged there, as shown in Figure 16. This test provided a qualitative test of the 
effectiveness of the system in a realistic application.
Figure 16.  Nanobarcode particles from explosive residue, magnetically extracted and imaged using the 
microfluidic system.
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An issue with misregistration between the reflectance and fluorescence image 
pairs was encountered with use of the custom stage and microfluidic card.  This, and the 
conclusion of project funding, prevented the full demonstration of the multiplex bioassay 
in the microfluidic format, but the successful demonstration of the constituent 
components and functions, as well as a somewhat simpler protocol for the extraction and 
imaging of explosive tag particles, provide encouragement that the full bioassay 
implementation is achievable.
Results/Technical Outcome
The project objectives were to demonstrate several technologies for advancing the 
capabilities of automated multiplex solution-array biodetection assays.  A novel 
automated system was demonstrated, using functionalized Nanobarcodes® particles as 
array elements.  The technical achievements can be summarized as follows:
1.  A multiplex biodetection assay was developed and implemented in the 
Nanobarcodes® format.  The assay detected simulants for bacterial, viral, and protein 
toxin agents.  This assay demonstrated performance similar to state of the art 
immunoassays implemented in more traditional formats, showing that the Nanobarcode 
format is highly viable for future systems with regard to assay sensitivity and specificity.
2.  A number of new techniques were demonstrated for the non-contact 
manipulation and alignment of conductive rod-shaped particles in solution, including the 
use of DC and AC fields, and the integration of magnetic stripes allowing manipulation 
and capture by external magnetic fields.  These techniques enable the efficient processing 
within compact microfluidic systems, and are applicable to other applications involving 
positional control of rod-shaped particles in solution.
3. A substantial database of new information regarding the electrokinetic 
properties of bio-functionalized metallic particles in aqueous solution was developed 
through experiment.  These include measurements of zeta potential with variation of 
particle material, solution pH, ionic strength, and surface functionalization state, 
including the performance of alternative self-assembled monolayer (SAM) coatings and 
the effect of protein conjugation.  This information is broadly useful to researchers 
developing nanoparticle technologies for biomedical and other applications.
4.  The ability of Nanobarcodes® particles to enable improved sample processing 
techniques and simplified readout within compact fluidic systems was verified.  By 
constructing and testing an automated microfluidic system for performing Nanobarcode 
based solution array tests, particle transport, trapping and extraction, and optical image 
readout using standard microscope optics were demonstrated. This also included a 
passive array alignment technique for minimizing particle touches and overlaps for 
optimal image analysis.
Areas that remain to be achieved in future work include the complete 
implementation of the assay sequence on the microfluidic card, as this had not been fully 
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demonstrated at the end of the project term (although subsets of the process had been 
demonstrated), and development of a more rugged, miniaturized, and automated optical 
image capture system.  While the card-integrated magnetic capture and ultrasonic 
resuspension devices have been demonstrated to function, their operating parameters and 
designs have not been optimized; further testing should be done in this area.  Finally, 
while software development was not part of the project, some improvements in the 
robustness of the image processing software should be achieved as part of a future system 
development effort.
This project yielded four archival journal articles (submitted or in preparation) 
and eight presentations at conferences and workshops.
Exit Plan
The primary follow-on opportunity is transition to system development work as 
part of the DOE and DHS–funded Chemical and Biological National Security Program.  
No new biodetection instrument development funding is available at the present time, so 
this will remain an option for future work.  Additional options have been explored in the 
areas of human protein expression testing for cancer biology (joint with Lawrence 
Berkeley National Lab) and nanorod alignment for advanced lithography applications 
(joint with the University of California – Berkeley).  
Summary
The project successfully demonstrated several new techniques for the next 
generation of particle-based, solution array biodetection assays.  At the conclusion, a 
prototype system for performing automated, Nanobarcode-based biodetection assays 
within a compact microfluidic format was constructed and tested.  In addition to the
technical goals of the project itself, a substantial amount of new scientific information on 
nanoparticle behavior in aqueous solutions has been added to the literature, which will 
benefit a broad range of future nanotechnology projects. 
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